首页> 外文期刊>Advances in Applied Ceramics >Preparation and characterisation of bioactive hydroxyapatite-silica composite nanopowders via sol-gel method for medical applications
【24h】

Preparation and characterisation of bioactive hydroxyapatite-silica composite nanopowders via sol-gel method for medical applications

机译:溶胶-凝胶法制备生物活性羟基磷灰石-二氧化硅复合纳米粉体及其表征

获取原文
获取原文并翻译 | 示例
           

摘要

This study focuses on preparation and characterisation of hydroxyapatite-silica composite nanopowders with different contents of silica. Hydroxyapatite-silica composite "nanopowders with 10, 20, 30 and 40 wt-% silica were prepared using a sol-gel method at 600°C with phosphoric pentoxide and calcium nitrate tetrahydrate as the source of hydroxyapatite, also tetraethylortho-silicate and methyltriethoxisilane as the source of silica. XRD, FTIR, SEM, EDAX and TEM techniques were used for characterisation and evaluation of the phase composition, crystallinity, crystallite size, functional groups, morphology and composition of the products. Dissolution behaviour of the products was evaluated at predetermined time periods by an atomic absorption spectrometer and a pH meter. Results indicated the presence of nanocrystalline hydroxyapatite phase and amorphous silica nanoparticles in composite nanopowders. Also, by increasing the content of silica in composite nanopowders, the crystallite size and crystallinity of hydroxyapatite phase decreased and the Ca ion release rate changed.
机译:这项研究的重点是具有不同二氧化硅含量的羟基磷灰石-二氧化硅复合纳米粉体的制备和表征。使用溶胶-凝胶法在600°C下用五氧化二磷和硝酸钙四水合物作为羟基磷灰石的来源,还用原硅酸四乙酯和甲基三乙氧基硅烷作为羟基磷灰石-二氧化硅复合材料``纳米粉体,采用10%,20%,30%和40%的二氧化硅制备用XRD,FTIR,SEM,EDAX和TEM技术表征和评估产物的相组成,结晶度,微晶尺寸,官能团,形态和组成,并在预定的条件下评估产物的溶解行为结果表明,复合纳米粉中存在纳米晶羟基磷灰石相和无定形二氧化硅纳米粒子;通过增加复合纳米粉中二氧化硅的含量,羟基磷灰石相的晶粒尺寸和结晶度降低, Ca离子释放速率发生了变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号